Call Options Transactions Made in Q3 2024 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q3 2024. The information is specifically focused on institutions that hold call options of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
37.7K+ 121.22% |
$90.1K - $132K
|
68.8K
$190K
|
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
3.4K+ 24.29% |
$8.13K - $11.9K
|
17.4K
$48K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-51.7K- 81.42% |
$124K - $180K
|
11.8K
$32.6K
|